The global insulin pumps market is expected to reach USD 10.25 Billion by 2028, according to a new report by Reports and Data. Insulin pumps are used for insulin therapy and is used for the treatment of patients with all types of diabetes.

The need for insulin therapy depends upon the balance between insulin resistance and insulin secretion. Patients with type 1 diabetes require insulin treatment permanently unless they receive a whole organ pancreas transplant or an islet. Type 2 diabetes patients require insulin as their beta-cell function lowers over time.

Diabetes and its complications, societal costs, and deaths have a huge and rapidly growing impact across the globe. In 2019: approximate 463 million adults (20-79 years) were living with diabetes, and by 2045, this is expected to rise to 700 million. A growing number of diabetic patients are propelling the demand for insulin.

Technological advancements in the insulin pumps have led to improved reliability and functionality. CSII (continuous subcutaneous insulin infusion) technology has observed several advancements, comprising the incorporation of continuous glucose monitoring (CGM) with the insulin pump. At present, these pumps with the integration of AI are capable of controlling the algorithm that analyzes the blood glucose level and automatically delivers the insulin to the individual using it.

The market in Asia Pacific is estimated to witness an increasing demand in the forecast period owing to growing awareness pertaining to medical treatments and care, rising health care sector, and an increase in RD activities. Further, a rapid increase in the diabetic population and increasing adoption of insulin administration are driving the market demand in the region.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.reportsanddata.com/download-free-sample/2346

Market Overview:

The global Insulin Pumps market has significantly grown over the recent past and is expected to register rapid growth over the forecast period. The pharma and healthcare sector is rapidly evolving with innovations in technology, increasing healthcare spending and improving healthcare facilities and systems. Many hospitals, ambulatory surgical care centers and clinics across the globe are adopting advanced devices and equipment. Revenue growth of the global Insulin Pumps market is significantly driven by factors such as increasing prevalence of chronic diseases, rapid advancements in healthcare and medical sector, high adoption of latest tools and techniques and growing funds by several public and private sectors. In addition, rising focus on drug development, increasing demand for precision medicine, high adoption of home care settings and point-of-care diagnostics, increasing investments in research and development activities are expected to drive global market revenue growth during the forecast period.

Competitive Outlook of the Global Insulin Pumps Market

The globla Insulin Pumps market study focuses on the revenue growth trajectories of the leading companies in this market. This section of the report throws light on the highly competitive landscape of the Insulin Pumps market, pointing out the major players. The report further discusses the strategic initiatives undertaken by each of these market players, including mergers acquisitions, collaborations, joint ventures, new product launches, new business deals, and technological innovations.

Top Companies Profiled in the Report:

Animus Corporation, Asante, Insulet Corporation, Nipro Diagnostic Inc., Cellnovo Ltd., Ypsomed Group, Medtronics Inc., Tandem Diabetes Care Inc., Roche, and Valeritas, among others.

Inquiry Before Buying @ https://www.reportsanddata.com/inquiry-before-buying/2346

The report is inclusive of product type outlook, application spectrum, end-use outlook, technology landscape, regional market analysis, and competitive overview.

Insulin Pumps Market Segmentation:

• Product Type Outlook (Revenue, USD Million; 2018-2028)
  • Traditional Insulin Pump
  • Disposable Insulin Pump

  Accessories Outlook (Revenue, USD Million; 2018-2028)

  • Insulin Set Insertion Devices
  • Insulin Cartridges
  • Battery

  End-User Outlook (Revenue, USD Million; 2018-2028)

  • Hospitals Clinics
  • Laboratories
  • Homecare settings

Geographic Segment Covered in the Report:

The Insulin Pumps report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country, and sub-region during the estimated period.

• North America (USA and Canada)
• Europe (UK, Germany, France and the rest of Europe)
• Asia Pacific (China, Japan, India, and the rest of the Asia Pacific region)
• Latin America (Brazil, Mexico, and the rest of Latin America)
• Middle East and Africa (GCC and rest of the Middle East and Africa)

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/2346

Thank you for reading our report. Customization of this report is available as per the client’s requirements. Please connect with us to know more about the report and our team will ensure you get the report tailored according to your needs.

Get Explore Latest Research Report by Reports and Data:

Scabies Treatment Market @ https://www.biospace.com/article/scabies-treatment-market-to-showcase-strong-cagr-between-2022-and-2030/

Keloid Market @ https://www.biospace.com/article/keloid-market-current-short-term-and-long-term-market-effects-analysis-report-by-2030/

Paraganglioma Market @ https://www.biospace.com/article/paraganglioma-market-deamd-2022-2030-rise-in-unhealthy-habits-such-as-excessive-alcohol-consumption-is-factor-ot-drive-industry-growth/

Chronic Fatigue Market @ https://www.biospace.com/article/chronic-fatigue-market-study-on-current-status-and-challenges-with-future-opportunities-to-2030/

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: [email protected]